Critical topics in ensuring data quality in bioanalytical LC-MS method development.
about
Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry.Assessment of tandem mass spectrometry and high-resolution mass spectrometry for the analysis of bupivacaine in plasma.Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.Bioanalytical LC-MS of therapeutic oligonucleotides.Current applications of high-resolution mass spectrometry in drug metabolism studies.Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.Current advances and strategies towards fully automated sample preparation for regulated LC-MS/MS bioanalysis.A simple, effective approach for rapid development of high-throughput and reliable LC-MS/MS bioanalytical assays.An investigation of the comparability of commercially sourced plasma and pharmaceutical study plasma, using total protein concentration.Investigation of microbore UPLC and nontraditional mobile phase compositions for bioanalytical LC-MS/MS.Mobile phase pH and organic modifier in reversed-phase LC-ESI-MS bioanalytical methods: assessment of sensitivity, chromatography and correlation of retention time with in silico logD predictions.High-Throughput HPLC-MS/MS Method for Quantification of Ibuprofen Enantiomers in Human Plasma: Focus on Investigation of Metabolite Interference.Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.Extraction methods for the removal of phospholipids and other endogenous material from a biological fluid.
P2860
Q34310103-79C5ECB8-4B0B-46FC-8C5C-A54E6F867AC1Q35627328-8DB372B9-AD8B-4A1B-B5F4-8A9FA92806B9Q36289481-F47600DD-F489-498C-8292-639A9331AEB9Q37851144-06740F35-7535-4777-9D90-83F40C55E5C1Q37986333-48BE1CF9-EFCE-41D0-AF52-D534D9DBA80AQ38196297-CD14EDAC-ACFC-42D9-A25C-5FE83D252DC9Q38266628-A771D329-AC07-4BDE-ACF1-2F0271982368Q40635817-03AC0479-846F-4BFB-96E2-AD81ACAED6D6Q46605343-E50DFE3B-F119-4C68-B205-3234C440A5C0Q50494799-70FAC838-38D8-4C83-9230-463FC6C46600Q51139874-9FF20C54-C5D2-40FF-9714-CF6B124DF63BQ51773888-931C3FF4-08AF-4869-BF0E-C53D21F38CE6Q52737161-F1F837C0-D3A0-4A8E-93BD-EBB41C04A0DCQ53394049-242658E1-5F7C-45E0-A005-FEA053F5D38B
P2860
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@ast
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@en
type
label
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@ast
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@en
prefLabel
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@ast
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@en
P2860
P356
P1433
P1476
Critical topics in ensuring data quality in bioanalytical LC-MS method development.
@en
P2093
Daniel E Mulvana
P2860
P304
P356
10.4155/BIO.10.60
P577
2010-06-01T00:00:00Z